Kenneth F. Bradstock

Author

Also Known As

K Bradstock, K F Bradstock, K. Bradstock, K. F. BRADSTOCK, K. F. Bradstock, K.F. Bradstock, KENNETH F. BRADSTOCK, Kenneth Bradstock, Kenneth F Bradstock, Kenneth F. BRADSTOCK

224

Publications

6.7K

Citations

H-Index

109

Concepts

All Affiliations

Westmead Hospital The University of Sydney Westmead Institute The Royal Melbourne Hospital Peter MacCallum Cancer Centre

About

Kenneth F. Bradstock is an author at Westmead Hospital specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	52	3.4K
2	Health Sciences	13	14	807
3	Public Health	2	2	72
4	Natural Sciences	1	1	36
5	Nursing	1	1	46

Kenneth F. Bradstock

104

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure Andrew Spencer, H. Miles Prince, Andrew W. Roberts, Journal of Clinical Oncology	2009	333
Terminal Transferase-Positive Human Bone Marrow Cells Exhibit the Antigenic Phenotype of Common Acute Lymphoblastic Leukemia George Janossy, Fred J. Bollum, Kenneth F. Bradstock, The Journal of Immunology Hematological MalignancyMembrane MarkersCell TherapyAutoimmune DiseaseTdt Enzyme	1979	235
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial C. Orla Morrissey, Sharon C.‐A. Chen, Tania C. Sorrell, The Lancet Infectious Diseases Invasive AspergillosisAntifungal AgentAntifungal AgentsClinical EpidemiologyPathology	2013	219
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase Susan Branford, Zbigniew Rudzki, Andrew Harper, Leukemia Chronic PhaseHematological MalignancyChronic Myeloid LeukemiaOncologyMedicine	2003	157
Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases George Janossy, A. V. Hoffbrand, Melvyn F. Greaves, British Journal of Haematology Mixed-phenotype Acute LeukemiaImmunologyDiagnosisPathologyImmunophenotyping	1980	151
Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice Julius Juaréz, Nadia Harun, Marilyn Thien, Blood	2011	150
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML Anna Brown, Peer Arts, Catherine Carmichael, Blood Advances Allelic VariantDevelopmental BiologySomatic MutationsSomatic VariantEpigenetic Regulation	2020	150
Activation of Wnt/β‐catenin pathway mediates growth and survival in B‐cell progenitor acute lymphoblastic leukaemia Naveed I. Khan, Kenneth F. Bradstock, Linda J. Bendall British Journal of Haematology Hematological MalignancyLymphoid NeoplasiaLymphocyte DevelopmentCell SignalingMedicine	2007	142
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment Julius Juaréz, Aileen Dela Peňa, Rana Baraz, Leukemia Hematological MalignancyCell TherapyInhibit EngraftmentMedicineImmunology	2007	136
Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning Kavita Raj, Antonio Pagliuca, Kenneth F. Bradstock, Biology of Blood and Marrow Transplantation Cell TherapyImmunologyTransplantation MedicineCell Replacement TherapyHaploidentical Donors	2014	136

Page 1